S. PYOGENES M49-16 ARGININE DEIMINASE INHIBITS PROLIFERATIVE ACTIVITY OF HUMAN PERIPHERAL BLOOD LYMPHOCYTES Текст научной статьи по специальности «Фундаментальная медицина»

Original articles Оригинальные статьи

Russian Journal of Infection and Immunity = Infektsiya i immunitet Инфекция и иммунитет

2021, vol. 11, no. 2, pp. 349-356 2021, Т. 11, № 2, с. 349-356

S. PYOGENES M49-16 ARGININE DEIMINASE INHIBITS PROLIFERATIVE ACTIVITY OF HUMAN PERIPHERAL BLOOD LYMPHOCYTES

E.A. Starikovaab, T.A. Leveshkoa, D.V. Churakinab, I.V. Kudryavtseva, L.A. Burovaa, I.S. Freidlina b c

a Institute of Experimental Medicine, St. Petersburg, Russian Federation b Pavlov First St. Petersburg State Medical University, St. Petersburg, Russian Federation c St. Petersburg State University, St. Petersburg, Russian Federation

Abstract. Arginine deiminase is one of three enzymes constituting the arginine deiminase system in bacteria. It was demonstrated that arginine deiminase exerts anti-proliferative effects on some primary and immortalized mouse and human cells. It is assumed that the inhibitory effect of arginine deiminase on cell proliferation might be related to its ability to result in the arginine exhaustion. T-lymphocytes depend on arginine for proliferation, T-cell receptor complex expression, and the differentiation of memory cells. The aim of the current study was to investigate an impact streptococcal arginine deiminase on functions of human peripheral blood lymphocytes. For this, we comparatively analyzed effects of Supernatant of Destroyed Streptococcal Cells (SDSCs) derived from parental strain S. pyogenes M49-16 and its isogenic mutant S. pyogenes M49-16delArcA bearing inactivated arginine deiminase gene (ArcA) on immune cell functions. An impact of supernatants on cell viability was estimated by staining with DAPI dye. Cell proliferation was assessed by MTT-test and flow cytometry by using the metho d based on intracellular protein staining with vital fluorescent CFSE (carboxyfluorescein succinimidyl ester) dye. In addition, the level of lymphocyte tyrosine phosphatase CD45 expression in various culturing conditions was evaluated. It was demonstrated that S. pyogenes M49-16 SDSCs had no impact on cells viability. Parental strain-derived SDSC exerted virtually no effect on intact cells proliferation, but considerably suppressed ConA-induced cell proliferation. At the same time, mutant strain-derived SDSC significantly stimulated spontaneous cell proliferation, but not that one after mitogen exposure. It was observed that increased proliferation was accompanied by upregulated CD45 expression, although it was not significant in all cases. These data allow to conclude that bacterial arginine deiminase could be one of pathogenicity factors able to limit lymphocyte proliferation and immune response and could be a part of pathogen strategy to suppress immune response in order to improve bacterial growth and dissemination.

Key words: arginine deiminase, Streptococcus pyogenes, lymphocytes, CFSE, proliferation, CD45.

АРГИНИНДЕИМИНАЗА S. PYOGENES M49-16 ПОДАВЛЯЕТ ПРОЛИФЕРАТИВНУЮ АКТИВНОСТЬ ЛИМФОЦИТОВ ПЕРИФЕРИЧЕСКОЙ КРОВИ ЧЕЛОВЕКА

Старикова Э.А.12, Левешко Т.А.1, Чуракина Д.В.2, Кудрявцев И.В.1, Бурова Л.А.1, Фрейдлин И.С.1,23

1 ФГБНУИнститут экспериментальной медицины, Санкт-Петербург, Россия

2 Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова, Санкт-Петербург, Россия

3 Санкт-Петербургский государственный университет, Санкт-Петербург, Россия

Резюме. Аргининдеиминаза является одним из трех ферментов, образующих систему аргининдеиминазы у бактерий. Ранее было установлено, что аргининдеиминаза, обладает антипролиферативным действием

Адрес для переписки:

Старикова Элеонора Александровна

197376, Россия, Санкт-Петербург, ул. Академика Павлова, 12,

Институт экспериментальной медицины.

Тел.: 8 (812) 234-16-69 (служебн.). Факс: 8 (812) 234-94-89.

E-mail: Starickova@yandex.ru

Для цитирования:

Старикова Э.А., Левешко Т.А., Чуракина Д.В., Кудрявцев И.В., Бурова Л.А., Фрейдлин И.С. Аргининдеиминаза S. pyogenes M49-16 подавляет пролиферативную активность лимфоцитов периферической крови человека // Инфекция и иммунитет. 2021. Т. 11, № 2. С. 349-356. doi: 10.15789/2220-7619-ADF-1363

© Starikova E.A. et al., 2021

Contacts:

Eleonora A. Starikova

197376, Russian Federation, St. Petersburg, Akademika Pavlova str., 12,

Institute of Experimental Medicine.

Phone: +7 (812) 234-16-69 (office). Fax: +7 (812) 234-94-89.

E-mail: Starickova@yandex.ru

Citation:

Starikova E.A., Leveshko T.A., Churakina D.V., Kudryavtsev I.V., Burova L.A., Freidlin I.S. S. pyogenes M49-16 arginine deiminase inhibits proliferative activity of human peripheral blood lymphocytes // Russian Journal of Infection and Immunity = Infektsiya i immunitet, 2021, vol. 11, no. 2, pp. 349-356. doi: 10.15789/2220-7619-ADF-1363

DOI: http://dx.doi.org/10.15789/2220-7619-ADF-1363

в отношении ряда первичных и иммортализованных клеток мыши и человека. Предполагается, что ингиби-рующее действие фермента может быть связано с его способностью приводить к истощению аргинина в микроокружении клеток. Биодоступность аргинина играет важную роль для пролиферации Т-лимфоцитов, экспрессии белков Т-клеточного рецептора и дифференцировки клеток памяти. Целью настоящего исследования стало изучение влияния аргининдеиминазы пиогенного стрептококка на функциональную активность лимфоцитов периферической крови человека. Для достижения поставленной цели было проведено сравнительное исследование влияния супернатанта разрушенных стрептококковых клеток (СРС) исходного штамма S. pyogenes M49-16 и его изогенного мутанта S. pyogenes M49-16delArcA с инактивированным геном аргининдеиминазы (ArcA) на функции иммунных клеток. Влияние супернатантов на жизнеспособность клеток оценивали методом проточной цитометрии, с использованием ДНК-связывающего красителя DAPI. Пролиферацию клеток оценивали с помощью МТТ-теста и цитофлуориметрически с использованием метода, основанного на окрашивании внутриклеточного белка витальным флуоресцентным красителем CFSE (кар-боксифлуоресцеинсукцинимидилэфирным красителем). Кроме того, в работе оценивали уровень экспрессии на лимфоцитах тирозинфосфатазы CD45 в различных условиях культивирования. Было показано, что СРС S. pyogenes M49-16 не оказывал влияния на жизнеспособность клеток. СРС исходного штамма практически не влиял на пролиферацию интактных клеток, но значительно подавлял пролиферацию клеток, индуцированную ConA. В то же время СРС мутантного штамма достоверно повышал спонтанную пролиферацию клеток и не оказывал влияния на пролиферацию, индуцированную митогеном. Было показано, что увеличение пролиферации сопровождалось увеличением уровня экспрессии CD45, однако эти изменения не во всех случаях были достоверны. Полученные данные позволяют заключить, что бактериальная аргининдеимина-за может являться одним из факторов патогенности, способных ограничивать пролиферацию лимфоцитов и развитие иммунного ответа с целью улучшения роста и диссеминации бактерий.

Ключевые слова: аргининдеиминаза, Streptococcus pyogenes, лимфоциты, CFSE, пролиферация, CD45.

Introduction

Arginine deiminase (AD) is one of three enzymes constituting the arginine deiminase system in bacteria [19]. The AD system is widespread among prokary-otes, and for Mycoplasma spp. L-arginine catabolism caused by this enzymatic complex serves as the main non-glycolytic energy source [4]. AD system protects bacteria from low pH with ammonia production and improves bacterial growth and biosynthesis processes with citrulline and ATP generation [4, 19]. Initially, streptococcal AD was isolated from S. hemolyticus Su strain cell extract in 1985 [33]. Enzyme which at that time was called "streptococci acid glycoprotein (SAGP)" was able to suppress proliferation of transformed hamster embryonic lung cells (THEL) [31]. Later on, the gene encoding this protein was characterized, cloned and expressed in E. coli system [17], and only in 1998 it was proved that the product of this gene possesses arginine hydrolyzing activity and has high homology with AD, previously extracted from Mycoplasma hominis, Mycoplasma arginini, Pseudomonas putida and Pseudomonas aeruginosa [8].

Subsequently, AD activity was also described for other S. pyogenes strains [6]. It was demonstrated that S. pyogenes AD, as well as homologous enzymes extracted from other microorganisms, displayed antiproliferative effect on a number of primary and immortalized mouse and human cells [7, 29, 30, 32]. Currently, researchers' attention is generally focused on studying mechanisms of anti-tumor impact of this enzyme [18]. Meanwhile, in an adult, immune cells as well as tumor cells show high transient prolifera-tive activity. Clonal expansion and differentiation lymphocytes into effectors and memory cells un-

derlies the adaptive immune response to infection. Arginine bioavailability is an important factor that regulates activation and proliferation of immune cells [23]. Arginine depletion in the site of infection could be a part of pathogen's strategy to suppress immune response in order to improve bacterial growth and dissemination. Thus, the investigation of bacterial AD influence on immune cells function in host organism requires detailed examination to be carried out. The objective of this research is to study S. pyogenes M49-16 AD influence on functions of human peripheral blood lymphocytes.

Materials and methods

Obtaining supernatant of ultrasonic destroyed streptococci. S. pyogenes M49-16 del ArcA strain was obtained and characterized as described earlier [26]. Supernatant of Destroyed Streptococcal Cells (SDSCs), containing biologically active intra-cellular components, were extracted from the cultures of parental S. pyogenes M49-16 and its isogenic mutant with arcA (AD) gene deletion S. pyogenes M49-16 delArcA. Streptococci were cultured within 18-20 hours at 37°C in Todd-Hewitt (Difco) medium in aerobic conditions, sedimented by centrifu-gation and washed twice with PBS (150 mM NaCl, 10 mM Na-phosphate buffer, pH 7.4), containing no liposaccharide. Concentration of bacterial cells suspension was standardized in accordance with optical density, and its amount was made up to 2.5-5 x 108 colony-forming units per milliliter. Ultrasonic disintegration of streptococci was carried out with the amount of 5 ml of bacterial suspension in PBS at pH 7.4 for 5 min, at frequency of 22 kHz and power

0.6—0.8 mA on a disintegrator (MSE). The completeness of bacterial cells destruction was controlled microscopically, after that the suspension was cen-trifuged at 1600g for 30 min. Received supernatants were then sterilized with use of Filtropur S filters with 0.45 ^m pore size (Sarstedt, Germany) and stored at -20°C.

Isolation of mononuclear cells from human peripheral blood. Healthy donors' blood of both sexes, aged from 20 up to 50 years old, was collected in a vacuum test tube with K3EDTA. To isolate mononuclear leukocytes, separation was carried out by cells sedimentation on Ficoll solution gradient with 1.077 g/cm3 density (Biolot, Russia). Blood sample was diluted by 3 times in Hanks's solution (Biolot, Russia), layered on Ficoll solution gradient (Biolot, Russia) and centrifuged in a horizontal rotor at 400g for 40 min. Mononuclear leukocytes were harvested and washed twice in 0.5 mM EDTA solution (Biolot, Russia) at 300g for 15 min at 4°C. Quantity of cells was then counted in Goryaev's chamber.

MTT cell proliferation assay. The impact of SDSCs on PBMCs proliferation was assessed by MTT-test, according to mitochondrial dehydrogenase activity [21]. The cells, isolated as described before, were placed in 96-well plates (Sarstedt, Germany) in concentration of 200 000 cells/100 ^l RPMI1640 culture medium (Biolot, Russia) supplemented with 10% of FBS (Invitrogen, USA), 50 ^g/ml of gentamycin (Biolot, Russia), 2 mM of glutamine (Biolot, Russia) and 50 ^M P-mercaptoethanol (Sigma-Aldrich, USA). For induction of cell proliferation 5 ^g/ml ConA (Sigma-Aldrich, USA) was used. SDSCs of parental and mutant strain were added in 1/50 and 1/100 dilution. No SDSCs were added to the control wells. The cells were cultured for 6 days at 37°C in humidified environment with 5% of CO2.

On the 3rd day of cultivation partial replacement of the cultural medium with the fresh one with supplements was performed. For the last 4 hours of experiment MTT was added to each well (Sigma-Aldrich, USA) in final concentration of 0.5 mg/ ml. After that 100 ^l of lysing buffer, containing 10% sodium dodecyl sulfate (Serva Electrophoresis, Germany) in 0.01N-HCl was added, and incubated at 37°C over night. Results were analyzed by spectrophotometer (Microplate reader, model 680, BioRad, USA) at the wavelength of 570 nm. Proliferation level was estimated according to optical density in wells. The results were shown in percentage. Optical density in the control wells, containing cultural medium was defined as 100%.

Cell proliferation assay by flow cytometry. For proliferation assessment we used a method based on in-tracellular protein staining by vital fluorescent CFSE (carboxyfluorescein succinimidyl ester) dye (Sigma-Aldrich, USA). Isolated, as described before, PBMCs were brought to concentration 1 x 106 cells per ml of Hanks solution (Biolot, Russia) with CFSE (Sigma-

Aldrich, USA) in final concentration of 0.5 ^g/ml and left for 10 min in water bath, at 37°C. After that the cells were washed twice by centrifugation at 300g, 4°C, for 15 min in cold Hanks solution containing 1% of FBS (Sigma-Aldrich, USA). CFSE stained PBMCs were placed in 24-well plate in concentration of 2 000 000 cells/ml RPMI 1640 culture medium (Biolot, Russia) containing 10% of FBS (Invitrogen, USA), 50 ^g/ml of gentamycin (Biolot, Russia), 2 mM of glutamine (Biolot, Russia) and 50 ^M P-mercaptoethanol (Sigma-Aldrich, USA). ConA at final concentration of 5 ^g/ml was used for proliferation induction. SDSCs of parental and mutant strains were added in 1/50 and 1/100 dilution. No SDSCs were added to the control wells. On the 3rd day of cultivation partial replacement of the cultural medium with the fresh one with supplements was carried out. After 6 -day cultivation the cells were harvested in cytometry test tubes (Beckman Coulter, USA) and stained with PC5 conjugated CD45 antibodies (Beckman Coulter, USA). For necrosis level assessment cellular suspension was stained with 300 nM of DNA-binding dye DAPI (Invitrogen, USA). Samples assessment was carried out by a flow cytometer Navios™ (Beckman Coulter, USA).

Statistical analysis. The differences between experimental group were tested for significance by Student's t-test for independent group. In all tests zero hypothesis was rejected at p > 0.05. Analysis were carried out using the Statistica 8.0 (StatSoft, USA).

Results

The influence of SDSCs on PBMCs proliferation (Table 1). Initially, cells were gated on the living (DAPI-negative) and CD45high (lymphocyte). It was demonstrated that under standard conditions of cultivation the proportion of lymphocytes which did not undergo any divisions made up to 99% (Table 2, Fig., bottom row). Parental strain SDSCs had an effect only in dilution 1/100, expressed in a significant increase in the proportion of cells experiencing 1 division. Incubation in presence of mutant strain SDSCs resulted in a significant increase in the persent-ages of cells undergoing up to 7 and 8 divisions with SDSCs 1/50 and 1/100 dilutions, respectively. Meanwhile, a significant decrease in the proportion of non-divided cells to 65% with maximum SDSC dilution was observed.

In case of ConA treatment the proportion of cells which underwent up to 8 divisions increased; simultaneously, the proportion of non-divided cells decreased up to 43% (Table 3, Fig., bottom row). Parental strain SDSC significantly suppressed ConA-induced proliferation that was expressed in doubling in the proportion of non-divided cells with a decrease in the proportion of divided ones. The strongest inhibiting effect of parental strain SDSC was observed in the maximum concentration (dilution 1/50). In contrast,

Table 1. The influence of SDSCs on PBMCs viability

Proportion of live DAPICD45hi cells (%, M±m, n = 5), after incubation

without SDSCs with SDSC М49-19 with SDSC M49-16delArcA

1/50 1/100 1/50 1/100

Culture medium (control) 71.3±9.03 71.6±5.32 71.6±4.36 71.4±4.31 74.2±3.36

ConA 5 Mg/ml 74.7±14.16 63.1±10.20* 62.9±11.99 62.1±26.27 70.6±24.58

Notes. * — statistically significant difference compared to the control (p < 0.05). A significant decrease In living cells proportion took place only In the presence of ConA and parental strain SDSC in dilution 1/50 and made up 10%. It is noteworthy that ConA and SDSCs of S. pyogenes M49-16 had no independent impact on cells viability.

Table 2. The influence of SDSCs on the human peripheral blood lymphocyte spontaneous proliferation

Number of divisions Proportion of CD45hi cells (M±m) which underwent corresponding number of divisions, after incubation with

Culture medium (control) SDSC М49-19 SDSC M49-16delArcA

1/50 1/100 1/50 1/100

0 98.7±0.3 91.3±4.5 85.3±6.8 65.3±6.4* 70.0±2.5*

1 1.2±0.31 3.3±1.12 4.5±1.31* 5.5±0.95* 5.1±0.88*

2 0.1±0.02 1.9±1.09 3.1±1.45 5.0±0.78* 4.7±0.61*

3 0.04±0.024 1.4±0.94 2.4±1.33 5.2±0.61** 4.9±0.42*

4 0.02±0.020 1.0±0.68 1.9±1.16 5.2±0.85** 4.8±0.41**

5 0 0.9±0.61 1.8±1.03 5.2±1.13** 4.3±0.18**

6 0 0.2±0.24 0.8±0.50 3.8±0.94* 3.2±0.33**

7 0 0.1±0.10 0.4±0.24 2.3±0.74* 1.9±0.31**

8 0 0 0.2±0.14 2.2±1.38 0.9±0.31**

Notes. * — statistically significant difference compared to the control; ** — statistically significant difference compared to the SDSC S. pyogenes M49-16 in corresponding dilution (p < 0.01).

mutant strain SDSC showed a weak inhibiting effect on ConA-induced lymphocytes proliferation. In this case the proportion of cells which underwent up to 4 divisions slightly decreased in presence of SDSC dilution 1/50.

Assessment of PBMCs proliferative activity was carried out with use of MTT-test. Parental strain SDSC had no impact on intact cells proliferation, but suppressed the proliferation induced by ConA

(Table 4). Mutant strain SDSC significantly stimulated spontaneous cell proliferation and had no significant impact on mitogen-induced proliferation.

The influence of SDSCs on CD45 tyrosine phosphatase expression. The mutant strain SDSC significantly enhanced CD45 expression on non-divided cells given that they were not stimulated by ConA. Herewith on dividing cells, CD45 expression significantly increased. PBMCs incubation in the pres-

10' Id2 10' Id1 № № 10' 102 № Id1 № № 10' Id2 10' 10' 102 №

CFSE CFSE CFSE CFSE CFSE CFSE

I H ~T] « ~T] « I l 300. j

i™ I i™- 1 i 300 I i,5°; , I i™- I iso. I

_[_"- | : ^J ; jjiJ J

10' id2 № id1 1d! id* ° 10' 102 10s 0 Id1 1d! 1d! 10' Id2 Id' 101 102 10s

CFSE CFSE CFSE CFSE CFSE CFSE

Figure. Effect of SDSCs on the human peripheral blood lymphocyte proliferation and CD45 expression Notes. Upper row. Representative dot plots show CD45 expression versus CFCE fluorescence. From left to right: culture media, M49-16, M49-16delArcA, ConA, ConA and M49-16, ConA and M49-16delArcA. Bottom row. Representative histograms show CFCE fluorescence. From left to right: culture media, M49-16, M49-16delArcA, ConA, ConA and M49-16, ConA and M49-16delArcA.

Table 3. The influence of SDSCs on the human peripheral blood lymphocyte proliferation induced by ConA

Number of divisions Proportion of cells (%, M±m) which underwent corresponding number of divisions, cultivated with

ConA (control) SDSC М49-19 SDSC M49-16delArcA

1/50 1/100 1/50 1/100

0 42.7±3.8 81.6±9.8* 69.6±9.9* 47.6±6.6$ 47.4±6.3

1 10.4±1.1 6.4±2.35 9.8±1.90 10.1±0.72 10.6±0.80

2 9.3±1.13 4.0±2.25 6.1±2.47 9.0±0.55 9.4±0.76

3 9.2±0.98 3.2±1.98* 6.0±2.23 8.4±0.65** 8.8±0.80

4 9.3±1.16 2.4±1.55* 4.7±1.88 7.5±0.95** 8.0±1.08

5 8.3±1.29 1.5±1.06* 2.4±1.31* 7.0±1.51** 7.3±1.53**

6 5.5±0.71 0.7±0.52* 1.1±0.60* 5.3±1.52** 5.1±1.30**

7 3.0±1.03 0.3±0.26* 0.3±0.27* 3.1±1.00** 2.4±0.42**

8 1.4±0.86 0 0.02±0.020 1.4±0.64 1.0±0.26**

Notes. * — statistically significant difference compared to the control; ** — statistically significant difference compared to the SDSC S. pyogenes M49-16 in corresponding dilution (p < 0.01).

ence of parental and mutant strains SDSCs caused a significant increase in CD45 expression on dividing cells not stimulated by mitogen, compared with control. But in this case, there was no significant difference in the effects showed by these two SDSC strains.

Under the influence of ConA, the expression of CD45 significantly increased on both non-divided and divided cells in comparison with the corresponding controls. The difference in the marker expression on divided and on non-divided cells was significant only for the parental strain SDSC. For the mutant strain SDSC, there was no significant difference between these parameters. (Tabl. 5, Fig., upper row).

Discussion

In current work the influence of streptococcal AD on functional activity of human peripheral blood lymphocyte was carried out. The study was carried out with S. pyogenes M49-16 isogenic mutant lacking the ability to make AD that has been constructed and characterized earlier [27]. An assay SDSCs prepared from the parental and mutant strains showed that significant AD activity was present in parental SDSC but none could be detected in mutant one [26]. It was established that parental and mutant strains SDSC did not exhibit toxic impact on human PBMCs (Tabl. 1). Cell death was observed to increase only in case of concomitant

Table 4. The influence of SDSCs on the PBMCs proliferation

Total proliferation level of PBMCs (%, M±m, N = 14) cultivated

without SDSCs with SDSC М49-19 with SDSC M49-16delArcA

1/50 1/100 1/50 1/100

Cultural medium (control) 100 87.4±9.32 93.0±11.28 147.2±13.77** 143.3±13.04**

Con A 5 mkg/ml 133.6±14.16* 101.3±10.20 106.3±11.99 174.4±26.27** 163.2±24.58**

Notes. * — statistically significant difference compared to the control; ** — statistically significant difference compared to the SDSC S. pyogenes M49-16 in corresponding dilution (p < 0.01).

Table 5. SDSCs impact on CD45 expression on PBMCs

Cell culturing in presence The level of CD45 expression, the mean fluorescence intensity (MFI, M±m, n = 4)

without ConA with ConA

non-dividing cells dividing cells non-dividing cells dividing cells

Culture media (control) 13.5±3.64 21.7±2.48*** 25.9±1.16** 40.5±7.45**

N49-19 1/50 17.5±1.16 30.9±1.81*** 20.7±1.77 34.7±3.29***

N49-19 1/100 18.1±0.83 35.8±5.14*** 19.9±2.84 37.0±4.72***

M49 -16delArcA1 /50 20.8±5.82* 37.5±3.31*** 31.5±1.67 47.5±13.02

M49-16delArcA1/100 23.4±4.83 40.2±6.27*** 28.1±4.77 40.6±9.47

Notes. * — expression level is significantly different from control (p < 0.05); ** — expression level is significantly lower than expression level with ConA; *** — expression level with SDS S. pyogenes M49-16 is significantly lower than expression level with SDS S. pyogenes M49-16 delArcA in corresponding dilution.

cells cultivation in presence of ConA and parental strain SDSC. Parental and mutant strains SDSCs had an opposite effect on the proliferation of untreated and ConA-stimulated cells. Parental strain SDSC slightly increased the level of spontaneous cells proliferation (Tabl. 2, Fig., bottom row) and, on the contrary, significantly suppressed proliferation induced by ConA (Tabl. 3, Fig., bottom row). Meanwhile, mutant strain SDSC had a significant stimulating effect on lymphocytes spontaneous proliferation (Tabl. 2, Fig., bottom row), but showed no effect on ConA-induced lymphocyte proliferation (Tabl. 3, Fig., bottom row).

Comparison of the effects of parental and mutant strains SDSC which differ by only one protein expression showed that AD is the factor which inhibits lymphocytes proliferation. These results confirm the data of other researchers demonstrating a decrease in proliferative activity of human PBMCs under the influence of AD obtained from commensal bacteria of oral cavity Granulicatella elegans [16]and pathogenic bacterium of S. pyogenes Manfredo strain [8].

It is assumed that the inhibitory effect of AD on lymphocytes proliferation could be caused by the enzyme's ability to result in the arginine exhaustion in the culture medium. There is a lot of data proving that argi-nine is necessary for lymphocytes proliferation, T-cell receptor expression and memory cells differentiation [3, 11, 23]. Arginine depletion is the central pathway that was used by arginase-expressing myeloid suppressor cells to limit effector T-cell functions [9, 10, 20, 24]. It is shown that myeloid suppressor cells cause inhibition of T lymphocytes proliferation in vitro due to decreased expression of T-cell receptor CD3Z chain [22]. Arginine is the substrate for both enzymes — arginase and AD, but metabolites of these enzymes are quite different. Unlike arginase, which converts arginine into ornithine, bacterial AD catalyzes arginine conversion in citrulline and the deficiency of arginine can be compensated by the re-synthesis of this amino acid from cit-rulline. It was shown that the proliferation of activated T lymphocytes reduced due to arginine deprivation in vitro could be restored with citrulline addition [2]. Besides, in the conditions of low arginine concentration an amino-acid transpoter CAT-1 expression and citrulline transport up-regulated in T lymphocytes [15]. In addition, argininosuccinate synthase expression increased providing citrulline conversion into arginine [2, 9, 28]. Therefore, the mechanisms of AD influence on the functional activity of lymphocytes may have their own features in comparison with the mechanisms defining the action of arginase.

References

In the current research it was discovered that parental and mutant strains SDSCs had an opposite effect on the proliferation of unstimulated and mitogen-stimulated cells. SDSCs comprise the factors, which stimulate lymphocytes proliferation. It is well known that S. pyogenes express a wide range of factors, which could act as super antigens, i. e. induce lymphocytes polyclonal activation. Among them are streptococcal pyrogenic exotoxins (SPEs) [25]. The effect of these substances was manifested when SDSC from the mutant strain, lacking AD, was added to PBMCs culture. However, AD could completely grade the mitogenic effect of these factors, since the parental strain SDSC, containing AD, exhibit no proliferating activity. It is probable that the presence of factors with opposite actions could allow a pathogen to adapt to the environmental conditions changing during infection. For example, SpeB plays an important role in early stages of local streptococcal infections [1, 12, 13]. Opposite, arginine depletion could be manifested later, when the bacterial load and AD output in the site of pathogen invasion dramatically increase. In our previous research, using murine model of streptococcal infection we found a gradual arginine decrease in blood showing the lowest values on the fifth day of postinfection [26].

In this work it was established that lymphocyte proliferative activity was correlated with CD45 ty-rosine phosphatase expression level (Tabl. 5, Fig., upper row). It is known that CD45 regulates various cell processes, including mitotic cycle, cell growth and differentiation. Intracellular domain CD45 possesses protein tyrosine phosphatase activity and plays an important role in signal transduction from T-cell receptor. CD45 activates Lck tyrosine phosphatase by removal of inhibiting phosphate group from ty-rosine [5]. It was established that CD45 regulates immune cells functions, changing their sensitivity to variety of activation factors [14]. Based on the obtained data it is impossible to claim for certain whether CD45 reduced expression caused cells proliferation inhibition or vice versa. It is quite possible that there is a positive regulatory relation between cells proliferative activity and CD45 expression.

In conclusion, due to inhibition of lymphocyte proliferation, bacterial AD could be one of patho-genicity factors that is able to limit immune cells activation. It is likely to restrict immune response to commensal microbiota but also be a part of pathogen's strategy directed to suppress adaptive immune response during infection.

1. Aziz R.K., Kotb M. Rise and persistence of global M1T1 clone of Streptococcus pyogenes. Emerg. Infect. Dis., 2008, vol. 14, no. 10, pp. 1511-1517. doi: 10.3201/eid1410.071660

2. Bansal V., Rodriguez P., Wu G., Eichler D.C., Zabaleta J., Taheri F., Ochoa J.B. Citrulline can preserve proliferation and prevent the loss of CD3 zeta chain under conditions of low arginine. J. Parenter. Enter. Nutr., 2004, vol. 28, pp. 423—430. doi: 10.1177/01 48607104028006423

3. Bronte V., Zanovello P. Regulation of immune responses by L-arginine metabolism. Nat. Rev. Immunol., 2005, no. 5, pp. 641- 654. doi: 10.1016/j.imbio.2007.09.008

4. Casiano-Colon A., Marquis R.E. Role of arginine deiminase system in protecting oral bacteria and an enzymatic basis for acid tolerance. Appl. Environ. Microbiol., 1988, vol. 54, pp. 1318-1324. doi: 10.1007/s00248-014-0535-x

5. Chang V.T., Fernandes R.A., Ganzinger K.A., Lee S.F., Siebold C., McColl J., Jönsson P., Palayret M., Harlos K., Coles C.H., Jones E.Y., Lui Y., Huang E., Gilbert R.J.C., Klenerman D., Aricescu A.R., Davis S.J. Initiation of T cell signaling by CD45 segregation at "close contacts". Nat. Immunol., 2016, vol. 17, no. 5, pp. 574-582. doi: 10.1038/ni.3392

6. Degnan B.A., Fontaine M.C., Doebereiner A.H., Lee J.J., Mastroeni P., Dougan G., Goodacre J.A., Kehoe M.A. Characterization of an isogenic mutant of Streptococcus pyogenes Manfredo lacking the ability to make streptococcal acid glycoprotein. Infect. Immun., 2000, vol. 68, no. 5,pp. 2441-2448. doi: 10.1128/iai.68.5.2441-2448.2000

7. Degnan B.A., Kehoe M.A., Goodacre J.A. Analysis of human T cell responses to group A streptococci using fractionated Streptococcus pyogenes proteins. FEMSImmunol. Med. Microbiol., 1997, vol. 17, no. 3,pp. 161-170. doi: 10.1111/j.1574-695X.1997. tb01009.x

8. Degnan B.A., Palmer J.M., Robson T., Jones C.E., Fischer M., Glanville M., Mellor G.D., Diamond A.G., Kehoe M.A., Goodacre J.A. Inhibition of human peripheral blood mononuclear cell proliferation by Streptococcus pyogenes cell extract is associated with arginine deiminase activity. Infect. Immun, 1998, vol. 66, no. 7, pp. 3050-3058. doi: 10.1128/IAI.66.7.3050-3058.1998

9. Fletcher M., Ramirez M.E., Sierra R.A., Raber P., Thevenot P., Al-Khami A.A., Sanchez-Pino D., Hernandez C., Wyczechowska D.D., Ochoa A.C., Rodriguez P.C. L-arginine depletion blunts antitumor T cell responses by inducing myeloid-derived suppressor cells. Cancer Res., 2015, vol. 75, pp. 275-283. doi: 10.1158/0008-5472.CAN-14-1491

10. Gabrilovich D.I., Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol., 2009, vol. 9, no. 3, pp. 162-174. doi: 10.1038/nri2506

11. Geiger R., Rieckmann J.C., Wolf T., Basso C., Feng Y., Fuhrer T., Kogadeeva M., Picotti P., Meissner F., Mann M., Zamboni N., Sallusto F. Lanzavecchia L-arginine modulates T cell metabolism and enhances survival and anti-tumor activity. Cell, 2016, vol. 167, no. 3,pp. 829-842. doi: 10.1016/j.cell.2016.09.031

12. Hamada S., Kawabata S., Nakagawa I. Molecular and genomic characterization of pathogenic traits of group A Streptococcus pyogenes. Proc. Jpn. Acad. Ser. B. Phys. Biol. Sci., 2015, vol. 91, no. 10, pp. 539-559. doi: 10.2183/pjab.91.539

13. Hamada S., Nakagawa I., Kawabata S. Genetic analysis and virulence factors of group A. streptococci that cause severe invasive infectious diseases. Tanpakushitsu Kakusan Koso, 2005, vol. 50, no. 3, pp. 253-261.

14. Hermiston M.L., Xu Z., Weiss A. CD45: a critical regulator of signaling thresholds in immune cells. Annu. Rev. Immunol., 2003, vol. 21, pp. 107-137. doi: 10.1146/annurev.immunol.21.120601.140946

15. Hyatt S.L., Aulak K.S., Malandro M., Kilberg M.S., Hatzoglou M. Adaptive regulation of the cationic amino acid transporter-1 (Cat-1) in Fao cells. J. Biol. Chem., 1997, vol. 272, pp. 19951-19957. doi: 10.1074/jbc.272.32.19951

16. Kanamoto T., Sato S., Nakashima H., Inoue M. Proliferation of mitogen-stimulated human peripheral blood mononuclear cells is inhibited by extracellular arginine deiminase of Granulicatella elegans isolated from the human mouth. J. Infect Chemother., 2007, vol. 13, no. 5, pp. 353-355. doi: 10.1007/s10156-007-0546-3

17. Kanaoka M., Fukita Y., Taya K., Kawanaka C., Negoro T., Agui H. Antitumor activity of streptococcal acid glycoprotein produced by Streptococcus pyogenes Su. Jpn. J. Cancer Res, 1987, vol. 78, no. 12, pp. 1409-1414. doi: 10.20772/cancersci1985.78.12_1409

18. Karpinski T.M., Adamczak A. Anticancer activity of bacterial proteins and peptides. Pharmaceutics, 2018, vol. 10, no. 2: 54. doi: 10.3390/pharmaceutics10020054

19. Marquis R.E., Bender G.R., Murray D.R., Wong A. Arginine deiminase system and bacterial adaptation to acid environments. Appl. Environ. Microbiol, 1987, vol. 53, no. 1, pp. 198-200. doi: 10.1128/AEM.53.1.198-200.1987

20. Murray P.J. Amino acid auxotrophy as immunological control nodes. Nat. Immunol., 2016, vol. 17, no. 2,pp. 132-139. doi: 10.1038/ ni.3323

21. Newman J.M.B., DiMaria C.A., Rattigan S., Steen J.T., Miller K.A., Eldershaw T.P.D., Clark M.G. Relationship of MTT reduction to stimulants of muscle metabolism. Chem.-Biol. Interact, 2000, vol. 128,pp. 127-140. doi: 10.1016/S0009-2797(00)00192-7

22. Nagaraj S., Schrum A.G., Cho H.I., Celis E., Gabrilovich D.I. Mechanism of T-cell tolerance induced by myeloid-derived suppressor cells. J. Immunol., 2010, vol. 184, no. 6, pp. 3106-3116. doi: 10.4049/jimmunol.0902661

23. Peranzoni E., Marigo I., Dolcetti L., Ugel S., Sonda N., Taschin E., Mantelli B., Bronte V., Zanovello P. Role of arginine metabolism in immunity and immunopathology. Immunobiology, 2007, vol. 212, pp. 795-812. doi: 10.1016/j.imbio.2007.09.008

24. Rodriguez P.C., Ochoa A.C., Al-Khami A.A. Arginine metabolism in myeloid cells shapes innate and adaptive immunity. Front. Immunol, 2017, no. 8: 93. doi: 10.3389/fimmu.2017.00093

25. Spaulding A.R., Salgado-Pabon W., Kohler P.L., Horswill A.R., Leung D.Y., Schlievert P.M. Staphylococcal and streptococcal superantigen exotoxins. Clin. Microbiol. Rev, 2013, vol. 26, no. 3,pp. 422- 447. doi: 10.1128/CMR.00104-12

26. Starikova E.A., Golovin A.S., Vasilyev K.A., Karaseva A.B., Serebriakova M.K., Sokolov A.V., Kudryavtsev I.V., Burova L.A., Voynova I.V., Suvorov A.N., Vasilyev V.B., Freidlin I.S. Role of arginine deiminase in thymic atrophy during experimental Streptococcus pyogenes infection. Scand. J. Immunol., 2019, vol. 89, no. 2: e12734. doi: 10.1111/sji.12734

27. Starikova E.A., Sokolov A.V., Vlasenko A.Y., Burova L.A., Freidlin I.S., Vasilyev V.B. Biochemical and biological activity of arginine deiminase from Streptococcus pyogenes M22. Biochem. Cell Biol. 2016, vol. 94, no. 2, pp. 129-137. doi:10.1139bcb-2015- 0069

28. Tarasenko T.N., Gomez-Rodriguez J., McGuire P.J. Impaired T cell function in argininosuccinate synthetase deficiency. J. Leukoc. Biol, 2015, vol. 97, pp. 273-278. doi: 10.1189/jlb.1AB0714-365R

29. Turenne C.Y., Wallace R., Behr M.A. Mycobacterium avium in the postgenomic era. Clin. Microb. Rev., 2007, vol. 20, no. 2, pp. 205-229. doi: 10.1128/CMR.00036-06

30. Yoshida J., Ishibashi T., Nishio M. Growth-inhibitory effect of a streptococcal antitumor glycoprotein on human epidermoid carcinoma A431 cells: involvement of dephosphorylation of epidermal growth factor receptor. Cancer Res., 2001, vol. 61, no. 16, pp. 6151-6157.

31. Yoshida J., Takamura S., Suzuki S. Cell growth-inhibitory action of SAGP, an antitumor glycoprotein from Streptococcus pyogenes (Su strain). Jpn. J. Pharmacol., 1987, vol. 45, no. 2, pp. 43-47. doi: 10.1254/jjp.45.143

32. Yoshida J., Takamura S., Suzuki S., Nishio M., Yoshida J. Streptococcal glycoprotein-induced tumour cell growth inhibition involves the modulation of a pertussis toxin-sensitive G protein. Br. J. Cancer. 1996, vol. 73, no. 8, pp. 917-923. doi:10.1038/ bjc.1996.182

33. Yoshida J., Yoshimura M., Takamura S., Kobayashi S. Purification and characterization of an antitumor principle from Streptococcus hemolyticus, Su strain. Jpn. J. Cancer Res., 1985, vol. 76, no. 3, pp. 213-223. doi: 10.20772/CANCERSCI1985.76.3 213

Авторы:

Старикова Э.А., к.б.н., старший научный сотрудник отдела иммунологии ФГБНУ Институт экспериментальной медицины, Санкт-Петербург, Россия; доцент кафедры иммунологии и ГБОУ ВПО Первый Санкт-Петербургский Государственный медицинский университет им. акад. И.П. Павлова МЗ РФ, Санкт-Петербург, Россия;

Левешко Т.А., лаборант отела иммунологии ФГБНУ Институт экспериментальной медицины, Санкт-Петербург, Россия; Чуракина Д.В., студент ГБОУ ВПО Первый Санкт-Петербургский Государственный медицинский университет им. акад. И.П. Павлова МЗ РФ, Санкт-Петербург, Россия; Кудрявцев И.В., к.б.н., старший научный сотрудник отдела иммунологии ФГБНУ Институт экспериментальной медицины, Санкт-Петербург, Россия; Бурова Л.А., д.м.н., ведущий научный сотрудник отдела молекулярной микробиологии ФГБНУ Институт экспериментальной медицины, Санкт-Петербург, Россия; Фрейдлин И.С., д.м.н., профессор, член-корреспондент РАН, главный научный сотрудник отдела иммунологии ФГБНУ Институт экспериментальной медицины, Санкт-Петербург, Россия; профессор кафедры иммунологии ГБОУ ВПО Первый Санкт-Петербургский Государственный медицинский университет им. акад. И.П. Павлова МЗ РФ; профессор кафедры фундаментальных проблем медицины и медицинских технологий ФГБОУ ВО Санкт-Петербургский государственный университет, Санкт-Петербург, Россия.

Поступила в редакцию 19.01.2020 Принята к печати 16.05.2020

Authors:

Starikova E.A., PhD (Biology), Senior Researcher, Department of Immunology, Institute of Experimental Medicine, St. Petersburg, Russian Federation; Associate Professor, Department of Immunology, Pavlov First St. Petersburg State Medical University, St. Petersburg, Russian Federation;

Leveshko T.A., Technician, Department of Immunology, Institute of Experimental Medicine, St. Petersburg, Russian Federation; Churakina D.V., Student, Pavlov First St. Petersburg State Medical University, St. Petersburg, Russian Federation; Kudryavtsev I.V., PhD (Biology), Senior Researcher, Department of Immunology, Institute of Experimental Medicine, St. Petersburg, Russian Federation;

Burova L.A., PhD, MD (Medicine), Leading Researcher, Department of Molecular Microbiology, Institute of Experimental Medicine, St. Petersburg, Russian Federation;

Freidlin I.S., PhD, MD (Medicine), Professor, RAS Corresponding Member, Head Researcher, Department of Immunology, Institute of Experimental Medicine, St. Petersburg, Russian Federation; Professor of the Department of Immunology, Pavlov First St. Petersburg State Medical University, St. Petersburg, Russian Federation; Professor of the Department of Fundamental Problems of Medicine and Medical Technologies, St. Petersburg State University, St. Petersburg, Russian Federation.

Received 19.01.2020 Accepted 16.05.2020